Singapore startup Galatek has raised 30 million USD in Series A funding to accelerate AI-driven auto...
The AMW Read
The article updates the player map for the Bio/Life Sciences vertical with a $30M Series A for Galatek, though it falls below the $500M threshold for cross.Β§D tagging.
NoveltySignificance
Healthcare & Bio Β· Player Map
Singapore startup Galatek has raised 30 million USD in Series A funding to accelerate AI-driven automation for the life sciences and semiconductor sectors. By integrating vision AI with their Abio software platform, the firm addresses precision gaps in smart laboratories and advanced packaging metrology. This move marks a shift toward cyber-physical infrastructure that unifies Asian supply chain efficiency with localized delivery in North America and Europe. Automating complex processes like 3D cell culture and wafer inspection is now a strategic necessity for industrial discovery at scale. #AI #Automation #Semiconductors #LifeSciences #VentureCapital
